This trial investigates whether supervised training in combination with hormonal substitution therapy has an impact on body composition, cardiovascular risk, risk for dementia, osteoporosis and insulin sensitivity in postmenopausal women.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Evaluation of the cardiovascular risk
Timeframe: +12 weeks; +24 weeks
Evaluation of the insulin sensitivity
Timeframe: +12 weeks, +24 weeks